These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2984129)
21. Radioprotection of pronormoblasts and normoblasts by WR-2721. Naruka K; Bhartiya HC Strahlenther Onkol; 1990 Aug; 166(8):542-4. PubMed ID: 2168582 [TBL] [Abstract][Full Text] [Related]
22. Radioprotection of the rat parotid gland by WR-2721: morphology at 60 days post-irradiation. Pratt NE; Sodicoff M; Liss J; Davis M; Sinesi M Int J Radiat Oncol Biol Phys; 1980 Apr; 6(4):431-5. PubMed ID: 6248498 [No Abstract] [Full Text] [Related]
23. Urinary prostaglandin and kallikrein excretion are not flow dependent in the rat. Fejes-Tóth G; Náray-Fejes-Tóth A; Rigter B; Frölich JC Prostaglandins; 1983 Jan; 25(1):99-103. PubMed ID: 6405455 [TBL] [Abstract][Full Text] [Related]
24. Radioprotective effect of WR-2721 in rabbits: a comparison with cystamine. Kuna P; Petýrek P; Jensovský V; Melek J Radiobiol Radiother (Berl); 1981; 22(5):644-52. PubMed ID: 6280232 [No Abstract] [Full Text] [Related]
25. Radiation protection of rat parenchymal hepatocytes with S-2-(3-aminopropylamino)ethylphosphorothioic acid. Jirtle RL; Pierce LJ; Crocker IR; Strom SC Radiother Oncol; 1985 Nov; 4(3):231-7. PubMed ID: 3001838 [TBL] [Abstract][Full Text] [Related]
26. Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiation. Meistrich ML; Finch MV; Hunter N; Milas L Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2099-107. PubMed ID: 6092308 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of reduction in the testicular weight by WR-2721 in relation to the body weight after whole-body gamma irradiation. Bhartiya HC; Jaimala Strahlenther Onkol; 1986 Jan; 162(1):68-70. PubMed ID: 3003944 [TBL] [Abstract][Full Text] [Related]
28. [Reducing late toxicity with amifostine in fractionated irradiation of the rat salivary glands]. Sagowski C; Wenzel S; Jenicke L; Bohuslavizki KH; Kehrl W; Zywietz F; Roeser K HNO; 2002 Sep; 50(9):822-8. PubMed ID: 12425136 [TBL] [Abstract][Full Text] [Related]
29. Protection of normal tissue against late radiation injury by WR-2721. Utley JF; Quinn CA; White FC; Seaver NA; Bloor CM Radiat Res; 1981 Feb; 85(2):408-15. PubMed ID: 6258191 [No Abstract] [Full Text] [Related]
30. [Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice]. Tanaka Y; Akagi K; Hasegawa T; Nakazawa M; Harima K; Murata T; Sawada S Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):700-9. PubMed ID: 6312407 [No Abstract] [Full Text] [Related]
31. Inhibitory effects of WR-2721 and cysteamine on tumor initiation in mammary glands of pregnant rats by radiation. Inano H; Onoda M; Suzuki K; Kobayashi H; Wakabayashi K Radiat Res; 2000 Jan; 153(1):68-74. PubMed ID: 10630979 [TBL] [Abstract][Full Text] [Related]
32. Radioprotective effect of WR-2721 on haematopoiesis in mice. I. Quantitative changes in haematopoiesis. Brezáni P; Macková N Radiobiol Radiother (Berl); 1988; 29(5):587-93. PubMed ID: 2852382 [No Abstract] [Full Text] [Related]
33. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Milas L; Hunter N; Reid BO; Thames HD Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288 [TBL] [Abstract][Full Text] [Related]
34. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection. Mendiondo OA; Connor AM; Grigsby P Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552 [TBL] [Abstract][Full Text] [Related]
35. A comparison of radioprotection from three neutron sources and 60Co by WR-2721 and WR-151327. Sigdestad CP; Grdina DJ; Connor AM; Hanson WR Radiat Res; 1986 May; 106(2):224-33. PubMed ID: 3010368 [TBL] [Abstract][Full Text] [Related]
36. Selenium pretreatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721. Weiss JF; Hoover RL; Kumar KS Free Radic Res Commun; 1987; 3(1-5):33-8. PubMed ID: 2854528 [TBL] [Abstract][Full Text] [Related]
37. Radioprotection of mouse skin vasculature and the RIF-1 fibrosarcoma by WR-2721. Penhaligon M Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1541-4. PubMed ID: 6090358 [TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agents WR-2721 and WR-77913. Dillon J; Kennedy JC; Pottier RH; Roberts JE Photochem Photobiol; 1988 Aug; 48(2):235-8. PubMed ID: 2851844 [No Abstract] [Full Text] [Related]
39. Modulation of cis-platinum renal toxicity by the radioprotective agent WR 2721. Jordan SW; Yuhas JM; Glick J Exp Mol Pathol; 1982 Jun; 36(3):297-305. PubMed ID: 6282619 [No Abstract] [Full Text] [Related]
40. Thromboxane and prostacyclin synthesis following whole body irradiation in rats. Schneidkraut MJ; Kot PA; Ramwell PW; Rose JC J Appl Physiol Respir Environ Exerc Physiol; 1984 Sep; 57(3):833-8. PubMed ID: 6386769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]